1686TiP Olaparib and durvalumab (MEDI4736) phase II study in patients with metastatic pancreatic cancer and DNA damage repair genes alterations
| Autor: | Macarulla, T., Castet, F., Lobo de Mena, M., Garcia-Carbonero, R., Martinez de Castro, E., Munoz Martin, A.J., Pazo Cid, R.A., Grana Suarez, B., Gallego Plazas, J., Alvarez, R., Ales Diaz, I.C., Gallego Jimenez, I., Laquente, B., Rodriguez, M., García Paredes, B., Cano Osuna, M.T., Ruiz de Mena, I., Fabregat-Franco, C., Espinosa Olarte, P., Aranda Aguilar, E. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S923-S923 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|